US Broker Ratings

Enovis Corporation (ENOV) Stock Analysis: Healthcare Innovator with a 62.54% Potential Upside

Enovis Corporation (NYSE: ENOV), a notable player in the healthcare sector specializing in medical devices, presents an intriguing investment opportunity with its current market dynamics. With a market capitalization of..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 19.42% Potential Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC) is garnering considerable attention from investors, particularly due to its significant 19.42% potential upside based on current analyst ratings. As a key player in the..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Eyeing a 62.94% Potential Upside

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) has caught the attention of investors with its significant potential upside of 62.94%. With its focus on behavioral healthcare services, Acadia plays a crucial..

Zai Lab Limited (ZLAB) Stock Analysis: Exploring a 148% Upside Potential in the Biotech Sector

For investors with a keen eye on the biotechnology sector, Zai Lab Limited (NASDAQ: ZLAB) presents a compelling opportunity. Based in China, Zai Lab operates at the forefront of healthcare..

BioCryst Pharmaceuticals (BCRX) Stock Analysis: A Promising 198% Potential Upside in the Healthcare Sector

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is capturing the attention of investors with its significant growth potential in the healthcare sector. With a market capitalization of $1.44 billion, BioCryst is a..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Biotech with 48% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) stands out in the biotechnology sector with a compelling growth trajectory and a robust pipeline of products targeting rare diseases. Based in Coral Gables, Florida,..

Alvotech (ALVO) Stock Analysis: A 382% Potential Upside in the Biosimilar Market

Investors looking for opportunities in the healthcare sector may find Alvotech (NASDAQ: ALVO) an intriguing option, with a staggering potential upside of 382.63% based on analyst ratings. Operating out of..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Uncovering Growth Potential Amidst Biotech Volatility

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Switzerland-based biotechnology company, is making waves in the healthcare sector with its innovative approach to inflammatory diseases. Despite being a relatively young company, having been..

Privia Health Group, Inc. (PRVA) Stock Analysis: Exploring a 29.71% Upside Potential in the Healthcare Sector

Privia Health Group, Inc. (NASDAQ: PRVA), a prominent player in the healthcare sector, has caught the attention of investors with its promising growth trajectory and impressive analyst ratings. As a..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: 31.25% Potential Upside Ignites Investor Interest

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a leader in the biotechnology sector, is capturing investor attention with its promising potential upside of 31.25%. This neuroscience-focused biopharmaceutical company, based in Burnaby, Canada,..

Envista Holdings Corporation (NVST) Stock Analysis: Potential Upside and Strategic Market Position

Envista Holdings Corporation (NYSE: NVST) stands as a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Brea, California, Envista is recognized for..

Metsera, Inc. (MTSR) Stock Analysis: Evaluating the Potential -19.15% Downside Amid Healthcare Innovations

Metsera, Inc. (NASDAQ: MTSR) is a key player in the biotechnology sector, focusing on developing innovative treatments for obesity and related diseases. As a clinical-stage company, Metsera is at the..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Exploring a 73.61% Potential Upside in the Medical Devices Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is making waves in the medical devices industry with its innovative solutions in the field of urology. Headquartered in San Jose, California, this surgical robotics..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: A Promising 21% Potential Upside in the Biotech Arena

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a key player in the biotechnology sector, is making waves with its focus on central nervous system (CNS) disorders and rare diseases. With a current..

Sotera Health Company (SHC) Investor Outlook: Exploring a 12.8% Potential Upside with Strong Buy Ratings

Sotera Health Company (NYSE: SHC) stands as a key player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $4.77 billion, Sotera Health..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating the Biotechnology Space with Promising Growth Prospects

PTC Therapeutics, Inc. (NASDAQ: PTCT), a key player in the biotechnology sector, has been making waves with its strategic focus on rare disorders, offering a beacon of hope to patients..

Alkermes plc (ALKS) Stock Analysis: Exploring a 53% Potential Upside in the Biopharma Sector

Alkermes plc (NASDAQ: ALKS), headquartered in Dublin, Ireland, is a notable entity within the healthcare sector, specifically focusing on the specialty and generic drug manufacturing industry. With a robust market..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Healthcare Innovator with 18% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) presents an intriguing opportunity for investors with its robust growth trajectory and strategic positioning in the healthcare sector. Specializing in the design and manufacture..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 32% Revenue Growth Powerhouse with Promising Prospects

Investors with an eye on the healthcare sector should take a closer look at TransMedics Group, Inc. (NASDAQ: TMDX), a key player in the medical devices industry. With a market..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Assessing a 9.88% Potential Upside for Investors

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, specializes in medical devices with a focus on life science research and clinical diagnostics. Founded in 1952 and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds